Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Original Contributions

Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment

Ball, Susan G. PhD*†; Atkinson, Sarah MD; Sparks, JonDavid PhD*; Bangs, Mark MD*; Goldberger, Celine MD*; Dubé, Sanjay MD†§

Author Information
Journal of Clinical Psychopharmacology: June 2015 - Volume 35 - Issue 3 - p 266-272
doi: 10.1097/JCP.0000000000000302
  • Buy


Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.